Skip to main content
. Author manuscript; available in PMC: 2023 Jan 3.
Published in final edited form as: Vaccine. 2021 Nov 19;40(1):133–140. doi: 10.1016/j.vaccine.2021.11.036

Figure 1. Immunization and bleeding schedule.

Figure 1.

Mice were immunized three times at 20 days intervals with 20 μg of rPvs48/45 formulated separately in Alhydrogel, GLA-SE or Montanide ISA-51 adjuvants. Blood samples were obtained at the indicated time points until day 180 for serology and functional assays. For days 0 and 40, the blood samples were collected before immunizations. EG: Experimental group; CG: Control group; Prot: recombinant protein